Today, headlines are running amok with the W.H.O. study that President Trump's touted and taken hydroxychloroquine, and its sister-drug, chloroquine, are ineffective against SARS-Cov-2 (the virus which supposedly causes Covid-19), and increases mortality, via heart problems, to patients.
Here is a link to the findings:
"Methods
We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. The registry comprised data from 671 hospitals in six continents. We included patients hospitalised between Dec 20, 2019, and April 14, 2020, with a positive laboratory finding for SARS-CoV-2."
"Results
96 032 hospitalised patients from 671 hospitals were diagnosed with COVID-19 between Dec 20, 2019, and April 14, 2020 and met the inclusion criteria for this study (figure 1). All included patients completed their hospital course (discharged or died) by April 21, 2020. Patients who were hospitalised during the study period without a completed course were unable to be analysed. The study cohort included 63 315 (65·9%) patients from North America, 16 574 (17·3%) from Europe, 7555 (7·9%) from Asia, 4402 (4·6%) from Africa, 3577 (3·7%) from South America, and 609 (0·6%) from Australia (details of the number of hospitals per continent are presented in the appendix, p 3). The mean age was 53·8 years (SD 17·6), 44 426 (46·3%) were women, mean BMI was 27·6 kg/m2 (SD 5·5; 29 510 [30·7%] were obese with BMI ≥30 kg/m2), 64 220 (66·9%) were white, 9054 (9·4%) were black, 5978 (6·2%) were Hispanic, and 13 519 (14·1%) were of Asian origin (appendix p 4). In terms of comorbidities, 30 198 (31·4%) had hyperlipidaemia, 25 810 (26·9%) had hypertension, 13 260 (13·8%) had diabetes, 3177 (3·3%) had COPD, 2868 (3·0%) had an underlying immunosuppressed condition, 16 553 (17·2%) were former smokers, and 9488 (9·9%) were current smokers. In terms of pre-existing cardiovascular disease, 12 137 (12·6%) had coronary artery disease, 2368 (2·5%) had a history of congestive heart failure, and 3381 (3·5%) had a history of arrhythmia. The mean length of stay in hospital was 9·1 days (SD 6·4), with an overall in-hospital mortality of 10 698 (11·1%) of 96 032. The use of other antivirals was recorded in 38 927 (40·5%) patients as treatment for COVID-19. The most common antivirals were lopinavir with ritonavir (12 304 [31·6%]), ribavirin (7904 [20·3%]), and oseltamivir (5101 [13·1%]). Combination therapy with more than one of these antiviral regimens was used for 6782 (17·4%) patients."
Wikipedia: "During the initial outbreak in Wuhan, China, the virus was commonly referred to as "coronavirus", "Wuhan coronavirus",[25][26][27] or "Wuhan virus".[28][29] In January 2020, the World Health Organisation recommended "2019 novel coronavirus" (2019-nCov)[30][5] as the provisional name for the virus."
"Human-to-human transmission of SARS-CoV-2 was confirmed on 20 January 2020, during the COVID-19 pandemic.[12][41][42][43]" https://en.wikipedia.org/wiki/Severe..._coronavirus_2
Obvious Questions:
If SARS-COV-2 was not identified until late January, 2020, how were so many patients admitted for it in December, 2019?
If SARS-COV-2 began in China, why was the largest set of patients from North America, followed by Europe?
Why were so many patients in the study already beset by co-morbidities?
It is well-established that the Covid-19 outbreak was engineered in 2019, with involvement by the Johns Hopkins center, Bill Gates, WHO, and the CDC, among other foundations and institutes. It is also well-established that Fort Detrick, which stored this "virus", was shut down twice last summer for breaches of security. Additionally, the American soldiers who were in Wuhan were already sick with the "virus" and unable to participate in the U.N. athletic competitions, and they infected the hotels and shops of Wuhan. Moreover, there is evidence of medical coverups in the U.S. in 2019, such as the vaping illness and other deaths whose coroner reports were not disseminated to the media. Science has already proven that it is metaphysically impossible for the "virus" to have started in Wuhan, because Wuhan's patients were afflicted by a mutated form.
Here is a link to the findings:
"Methods
We did a multinational registry analysis of the use of hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19. The registry comprised data from 671 hospitals in six continents. We included patients hospitalised between Dec 20, 2019, and April 14, 2020, with a positive laboratory finding for SARS-CoV-2."
"Results
96 032 hospitalised patients from 671 hospitals were diagnosed with COVID-19 between Dec 20, 2019, and April 14, 2020 and met the inclusion criteria for this study (figure 1). All included patients completed their hospital course (discharged or died) by April 21, 2020. Patients who were hospitalised during the study period without a completed course were unable to be analysed. The study cohort included 63 315 (65·9%) patients from North America, 16 574 (17·3%) from Europe, 7555 (7·9%) from Asia, 4402 (4·6%) from Africa, 3577 (3·7%) from South America, and 609 (0·6%) from Australia (details of the number of hospitals per continent are presented in the appendix, p 3). The mean age was 53·8 years (SD 17·6), 44 426 (46·3%) were women, mean BMI was 27·6 kg/m2 (SD 5·5; 29 510 [30·7%] were obese with BMI ≥30 kg/m2), 64 220 (66·9%) were white, 9054 (9·4%) were black, 5978 (6·2%) were Hispanic, and 13 519 (14·1%) were of Asian origin (appendix p 4). In terms of comorbidities, 30 198 (31·4%) had hyperlipidaemia, 25 810 (26·9%) had hypertension, 13 260 (13·8%) had diabetes, 3177 (3·3%) had COPD, 2868 (3·0%) had an underlying immunosuppressed condition, 16 553 (17·2%) were former smokers, and 9488 (9·9%) were current smokers. In terms of pre-existing cardiovascular disease, 12 137 (12·6%) had coronary artery disease, 2368 (2·5%) had a history of congestive heart failure, and 3381 (3·5%) had a history of arrhythmia. The mean length of stay in hospital was 9·1 days (SD 6·4), with an overall in-hospital mortality of 10 698 (11·1%) of 96 032. The use of other antivirals was recorded in 38 927 (40·5%) patients as treatment for COVID-19. The most common antivirals were lopinavir with ritonavir (12 304 [31·6%]), ribavirin (7904 [20·3%]), and oseltamivir (5101 [13·1%]). Combination therapy with more than one of these antiviral regimens was used for 6782 (17·4%) patients."
Wikipedia: "During the initial outbreak in Wuhan, China, the virus was commonly referred to as "coronavirus", "Wuhan coronavirus",[25][26][27] or "Wuhan virus".[28][29] In January 2020, the World Health Organisation recommended "2019 novel coronavirus" (2019-nCov)[30][5] as the provisional name for the virus."
"Human-to-human transmission of SARS-CoV-2 was confirmed on 20 January 2020, during the COVID-19 pandemic.[12][41][42][43]" https://en.wikipedia.org/wiki/Severe..._coronavirus_2
Obvious Questions:
If SARS-COV-2 was not identified until late January, 2020, how were so many patients admitted for it in December, 2019?
If SARS-COV-2 began in China, why was the largest set of patients from North America, followed by Europe?
Why were so many patients in the study already beset by co-morbidities?
It is well-established that the Covid-19 outbreak was engineered in 2019, with involvement by the Johns Hopkins center, Bill Gates, WHO, and the CDC, among other foundations and institutes. It is also well-established that Fort Detrick, which stored this "virus", was shut down twice last summer for breaches of security. Additionally, the American soldiers who were in Wuhan were already sick with the "virus" and unable to participate in the U.N. athletic competitions, and they infected the hotels and shops of Wuhan. Moreover, there is evidence of medical coverups in the U.S. in 2019, such as the vaping illness and other deaths whose coroner reports were not disseminated to the media. Science has already proven that it is metaphysically impossible for the "virus" to have started in Wuhan, because Wuhan's patients were afflicted by a mutated form.
Originally Posted by Optional 
